Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in Australia
41 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Where
- Brisbane, Clayton, Fitzroy, Kogarah
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT06901531 · EU 2024-519773-19-00 - Phase 2/3Taking peopleA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- Where
- Birtinya, Clayton, Elizabeth Vale, Liverpool, Melbourne, Murdoch
- Age
- 18 years and over
- People
- 690 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07221149 · EU 2025-523263-37-00 - Phase 1Taking peopleA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Where
- Darlinghurst, Nedlands
- Age
- 18 years and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00 - Phase 2Taking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Blacktown, Southport, Sydney
- Age
- 18 years and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - Phase 1/2Taking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Ballarat, Camperdown, Frankston, Saint Leonards, Waratah
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - Phase 2Taking peoplePsilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
- Where
- Abbotsford, Leederville, Melbourne, Northcote
- Age
- 18 years to 80 years
- People
- 87
- Run by
- Psyence Australia Pty Ltd
See details and how to joinNCT07072728 - Phase 1Taking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Auchenflower, Heidelberg, Kurralta Park
- Age
- 18 years and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470 - Phase 2Taking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Camperdown, Chermside, Clayton, Hobart, Hyde Park
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Blacktown, Mount Kuring-Gai, St Leonards, Subiaco, Woolloongabba
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 1/2Taking peopleA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Where
- Birtinya, Blacktown, Brisbane, Camperdown, Concord, Gold Coast, Nedlands, New Lambton Heights, Sydney, Waratah
- Age
- 18 years and over
- People
- 862 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05914116 - Phase 3Taking peopleA Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
- Where
- Darlinghurst, Heidelberg, Murdoch, Westmead
- Age
- 18 years and over
- People
- 840 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06764875 · EU 2024-512583-57-00 - Phase 3Taking peopleSonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Where
- Darlinghurst, Garran, Heidelberg, Murdoch, Randwick, Westmead, Woolloongabba
- Age
- 18 years and over
- People
- 2,130 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07431281 · EU 2024-519787-40-00 - Phase 1Taking peopleStudy to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
- Where
- Camperdown, Heidelberg
- Age
- 18 years and over
- People
- 325 worldwide
- Run by
- AbbVie
See details and how to joinNCT06084481 · EU 2023-506227-29-00 - Phase 1Taking peopleA Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid Tumors
- Where
- Darlinghurst
- Age
- 18 years and over
- People
- 66 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07801508 - Phase 1/2Taking peopleA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Where
- Adelaide, Blacktown, Darlinghurst, Frankston, Heidelberg, Melbourne, Nedlands, Southport, Wollstonecraft
- Age
- 18 years and over
- People
- 1,438 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07070232 · EU 2024-517261-16-00 - Phase 1/2Taking peopleA Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Where
- East Melbourne
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07115043 - Phase 2Taking peopleAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Melbourne, Murdoch, Randwick
- Age
- 18 years and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - Phase 1Taking peopleIKS014 in Advanced Solid Tumors That Express HER2
- Where
- Concord, Frankston, Melbourne, Nedlands, Sydney, Westmead
- Age
- 18 years and over
- People
- 165 worldwide
- Run by
- Iksuda Therapeutics Ltd.
See details and how to joinNCT05872295 - Phase 1/2Taking peopleEvaluation of XYA02 in Patients With Advanced Solid Tumors
- Where
- Melbourne, Perth, Sydney
- Age
- 18 years and over
- People
- 190
- Run by
- XYone Therapeutics, Inc
See details and how to joinNCT07670312 - Phase 1/2Taking peopleClinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- Where
- Adelaide, Melbourne, Perth, Sydney
- Age
- 18 years and over
- People
- 147 worldwide
- Run by
- Yuhan Corporation
See details and how to joinNCT05523947 - Phase 1Taking peopleA Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Where
- Adelaide, Brisbane, Camperdown, Geelong, Sydney
- Age
- 18 years and over
- People
- 76 worldwide
- Run by
- Kivu Bioscience Inc.
See details and how to joinNCT07229313 - Phase 1/2Taking peopleStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Where
- Bedford Park, Clayton, Frankston, Heidelberg, Melbourne, Miranda, Saint Albans
- Age
- 18 years and over
- People
- 159 worldwide
- Run by
- Aulos Bioscience, Inc.
See details and how to joinNCT05267626 - Phase 1/2Taking peopleSL-28 for Advanced Solid Tumours
- Where
- Adelaide, Gold Coast, Sydney
- Age
- 18 years and over
- People
- 60
- Run by
- Second Life Therapeutics
See details and how to joinNCT07341737 - Phase 2Taking peopleStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Where
- Clayton, Nedlands
- Age
- 18 years to 64 years
- People
- 257 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00 - Phase 1/2Active, not recruitingSafety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
- Where
- Adelaide, Clayton, Randwick, Southport
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06750185